Tardive Dyskinesia (TD) is a movement disorder resulting from prolonged use of certain medications, often with psychiatric implications. The Journal of Clinical Psychiatry offers comprehensive insights into TD, from its pathophysiology to management strategies. Our expert editors ensure that the content is both clinically relevant and actionable, aiding psychiatrists in diagnosing, preventing, and treating this challenging condition.
Tardive Dyskinesia
Recently published articles about Tardive Dyskinesia
Narrative Review
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials
April 29, 2026
The TDIS followed a similar trajectory to other clinician- and patient-reported outcomes measured in tardive dyskinesia clinical trials, and a change of 4 points in total score is considered...
Recent JCP Articles on Tardive Dyskinesia
Recent PCC Articles on Tardive Dyskinesia
Case Report
Tardive Dyskinesia in Schizoaffective Disorder With Diabetes and Kidney Disease
February 18, 2021
In this report, the authors describe the successful management of tardive dyskinesia with quetiapine in a man with schizoaffective disorder and comorbid diabetes with renal and neurologic complications as...
